MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+35.05%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$707M
AUM Growth
+$707M
(+32%)
Cap. Flow
+$64.9M
Cap. Flow
% of AUM
9.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
ONCR
Oncorus, Inc.
ONCR
|
$92.1M |
Top Sells
| 1 |
Syndax Pharmaceuticals
SNDX
|
$27.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iTeos Therapeutics
ITOS
| $125M | 17.74% | 3,706,663 | – | – |
|
|
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $125M | 17.73% | 4,050,865 | – | – |
|
3
Dyne Therapeutics
DYN
$1.92B
| $104M | 14.71% | 4,951,303 | – | – |
|
4
Repare Therapeutics
RPTX
$71.7M
| $103M | 14.58% | 3,003,772 | – | – |
|
|
ONCR
5
DELISTED
Oncorus, Inc.
ONCR
| $92.1M | 13.04% | +2,849,464 | New | +$92.1M |
|
|
HARP
6
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $75.2M | 10.63% | 4,524,425 | – | – |
|
7
Rhythm Pharmaceuticals
RYTM
$6.85B
| $56.8M | 8.03% | 1,909,258 | – | – |
|
|
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $25M | 3.53% | 5,736,296 | – | – |
|
|
9
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – | -1,843,388 | Closed | -$27.2M |
|